Stroke News

The Society for Vascular Surgery announced CMS expanded coverage for transcarotid artery revascularization to include standard surgical risk patients within its Vascular Quality Initiative TCAR Surveillance Project.

A sensor-equipped computer program was nearly 80% effective in identifying and counting arm movements in patients undergoing stroke rehabilitation, researchers from NYU Grossman School of Medicine announced.

DENVER – Individuals who had migraine with aura were more likely to have atrial fibrillation compared with those who had a migraine without aura, a presenter said at the American Headache Society annual meeting.

Inclisiran effectively and safely lowered LDL in patients with hyperlipidemia and prior cerebrovascular disease, according to a pooled analysis of the three ORION trials presented at the National Lipid Association Scientific Sessions.

Among patients with cryptogenic stroke, ipsilateral complicated carotid artery plaque detected by MRI was associated with elevated risk for recurrent ischemic stroke or transient ischemic attack, data show.

SAN DIEGO — Minimal long-term cardiac safety findings were reported with ozanimod treatment in patients with ulcerative colitis and relapsing multiple sclerosis, according to research presented at Digestive Disease Week 2022.

Zetia and proprotein convertase subtilisin/kexin type 9 inhibitors may reduce nonfatal myocardial infarction and stroke in adults with high or very high cardiovascular risk, according to findings published in The BMJ.

Implementation of an interactive training program increased clinician adherence to stroke guidelines and reduced the proportion of disabled or deceased patients with acute ischemic stroke, researchers reported in JAMA Network Open.

WASHINGTON — In the ADAPT-TAVR trial of patients who had transcatheter aortic valve replacement and no indication for long-term anticoagulation, edoxaban did not improve leaflet thrombosis compared with dual antiplatelet therapy.

U.S. death data show the burden of ischemic heart disease, cerebrovascular disease and HF deaths vary significantly across Asian American subgroups, emphasizing the importance of tailoring CVD prevention and management strategies.